oseltamivir has been researched along with Fever in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (18.75) | 29.6817 |
| 2010's | 38 (59.38) | 24.3611 |
| 2020's | 14 (21.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chon, I; Fujio, K; Hamabata, H; Jiaming, L; Kawashima, T; Kitano, A; Kodo, N; Masaki, H; Minato, M; Ono, Y; Phyu, WW; Saito, R; Saito, T; Sato, I; Shirahige, Y; Suzuki, E; Wagatsuma, K; Watanabe, H; Yuyang, S | 1 |
| Ding, YL; Hu, CC; Li, WF; Yuan, B | 1 |
| Bai, X; Chen, G; Fan, X; Li, Y; Tian, Y; Wang, K; Wang, W; Xi, S; Zhao, Y | 1 |
| Hayashida, S; Morioka, I; Nagano, N; Nezu, K; Udagawa, S | 1 |
| Hibino, A; Kondo, H; Mawatari, M; Odagiri, T; Saito, R; Shobugawa, Y; Tanabe, I; Yagami, R | 1 |
| Bass, L; Cohen, A; Dowdell-Smith, CP; Foradori, D; Iacobas, I; Laufman, J; Owolabi, FS | 1 |
| Akyollu, B; Arpali, E; Kocak, B; Tekin, S; Turkmen, A; Yelken, B | 1 |
| Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T | 1 |
| Bongard, E; Butler, CC; Cianci, D; Coenen, S; de Paor, M; Gobat, N; Goossens, H; Ieven, M; Saville, BR; van der Velden, AW; Verheij, TJ | 1 |
| Firouzabadi, FD; Firouzabadi, MD; Ghalehbaghi, B; Goudarzi, S; Jahandideh, H; Roomiani, M | 1 |
| Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A | 1 |
| Chon, I; Kawashima, T; Kodo, N; Ono, Y; Osada, H; Phyu, W; Saito, R; Saito, T; Sato, I; Shimada, Y; Shobugawa, Y; Wagatsuma, K | 1 |
| Bakheet, N; El-Shazly, M; Fouad, R; Hussin, W; Kassem, AM | 1 |
| Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M | 1 |
| Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L | 1 |
| Chen, RS; Chen, YM; Deng, L; He, CH; Liao, JY; Lin, CX; Lin, GY; Lin, JH; Liu, CY; Peng, Q; Wang, SJ; Zhang, T; Zheng, XF | 1 |
| Liese, JG; Prifert, C; Sauerbrei, A; Schmidt-Ott, R; Streng, A; Weissbrich, B | 1 |
| Bahirwani, J; Gonakoti, S; Maddala, RNM; Vidyasagar, S | 1 |
| Beutels, P; Bongard, E; Brugman, C; Butler, CC; Chlabicz, S; Coenen, S; Colliers, A; Cook, J; Davies, M; de Jong, M; De Paor, M; De Sutter, A; Francis, NA; Glinz, D; Godycki-Ćwirko, M; Goossens, H; Holmes, J; Ieven, M; Lindbaek, M; Little, P; Martinón-Torres, F; Moragas, A; Munck Aabenhus, R; Pauer, J; Pfeiferová, M; Radzeviciene-Jurgute, R; Saville, B; Sundvall, PD; Torres, A; Touboul, P; van der Velden, AW; Varthalis, D; Verheij, T | 1 |
| Barisione, G; Bruzzone, B; Butera, F; Grammatico, F; Guarona, G; Murdaca, G; Orsi, A; Schenone, S; Setti, M; Tisa, V | 1 |
| Blazquez, D; Bueno, M; Calvo, C; Carrasco, J; Cilleruelo, MJ; de Blas, A; de José, MI; Escosa, L; García-García, ML; Guillén, S; Llorente, M; Mazagatos, D; Méndez-Echevarría, A; Otheo, E; Santos, M; Tarrago, A; Tomatis, C; Tovizi, M | 1 |
| Ning, J | 1 |
| de Briel, D; Heller, R; Martin, A; Martinot, M; Mohseni-Zadeh, M; Mothes, A; Sagot, E; Souply, L | 1 |
| Bamba, M; Ichikawa, M; Ide, Y; Kawakami, C; Kawaoka, Y; Mitamura, K; Sakai-Tagawa, Y; Sugaya, N; Yamaguchi, Y; Yamazaki, M; Yasuhara, R | 1 |
| Miyazaki, C; Momoi, M; Nakamura, Y; Ohkusa, Y; Okabe, N; Sugawara, T; Taniguchi, K | 1 |
| Blaser, MJ; Buffa, R; Cabras, S; Contreras, M; Dominguez-Bello, MG; Hidalgo, G; Magris, M; Marini, E; Ortiz, V; Sanchez, W; Urbaez, M | 1 |
| Chazono, K; Fukushima, A; Hashimoto, Y; Iwajima, Y; Maeda, Y; Ohsawa, M; Ono, H; Yamamoto, S | 1 |
| Biçer, S; Ercan Sariçoban, H; Ergenekon Ulutaş, P; Gürol, Y; Özelgün, B; Özen, AO; Saf, C; Vitrinel, A; Yilmaz, G | 1 |
| Azziz-Baumgartner, E; Blanco, N; Bonilla, L; Chacon, R; Clara, WA; Guzman, G; Jara, J; Minaya, P; Mirza, S; Moreno, L; Palekar, R; Paredes, A; Rodriguez, D; Then, CJ | 1 |
| Andrianova, E; Averyanov, A; Bart, B; Epstein, O; Minina, E; Putilovskiy, M; Rafalsky, V | 1 |
| Ichikawa, M; Kawakami, C; Kawaoka, Y; Mitamura, K; Sugaya, N; Tamura, D; Yamazaki, M | 1 |
| Crawford, SM | 1 |
| Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawamura, K; Kawashima, T; Maeda, T; Matsuura, S; Nishimura, M; Tanaka, O; Yamauchi, S | 1 |
| Chan, M; Chow, AL; Cui, L; Krishnan, P; Lee, CC; Leo, YS; Lim, PL; Ling, LM; Lye, DC; Tan, AS; Win, NN | 1 |
| Bender, M; Bernheisel, C | 1 |
| Baranovich, T; Dapat, C; Dapat, IC; Ishitani, N; Matsuda, R; Oguma, T; Saito, R; Sato, I; Suzuki, H; Suzuki, Y; Zaraket, H | 1 |
| Lu, H; Shen, Y | 1 |
| Bilgin, H; Odabas, D; Sert, A; Yazar, A | 1 |
| Calitri, C; Cuozzo, M; Gabiano, C; Garazzino, S; Pinon, M; Scolfaro, C; Tovo, PA; Zoppo, M | 1 |
| Amayiri, N; Madanat, F | 1 |
| Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Maeda, T; Matsuura, S; Nishimura, M; Tanaka, O; Yamauchi, S | 1 |
| Dembiński, Ł; Jackowska, T; Marczyńska, M; Radzikowski, A; Smalisz-Skrzypczyk, K; Talarek, E | 1 |
| Abid, S; Cuffari, C; Liu, D; Montecalvo, M; Nadelman, RB; Sandoval, C; Seiter, K; Shah, D; Shi, Q; Sinaki, B | 1 |
| An, Y; Cao, B; Cao, ZX; Dong, JP; Gu, L; Guo, YM; He, XS; Hu, K; Jiang, LD; Li, XW; Liang, LR; Liang, ZA; Liu, QQ; Liu, YL; Sun, YH; Wang, C; Wang, YG; Wen, XM; Yang, T; Zou, ZQ | 1 |
| Cho, HJ; Cho, YK; Kim, YN; Ma, JS | 1 |
| Doniwa, K; Egashira, K; Hirotsu, N; Ikematsu, H; Iwaki, N; Iwakuni, O; Kashiwagi, S; Kawai, N; Kawashima, T; Kondou, K; Maeda, T; Tanaka, O; Yamaji, K | 1 |
| Ajisaka, K; Ikematsu, H; Kashiwagi, K; Kashiwagi, S; Masui, S; Nabeshima, S; Takeoka, H | 1 |
| Chang, LY; Huang, LM; Kao, CL; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Tsou, TP; Yang, PC | 1 |
| Duwe, S; Karsch, K; Louis, F; Muehlhans, S; Rath, B; Schweiger, B; Skopnik, H; Tief, F; Tuerk, E; von Kleist, M | 1 |
| Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawashima, T; Maeda, T; Ukai, H | 1 |
| Blanchon, T; Carrat, F; Duval, X; Flahault, A; Leport, C; Mentré, F; Mosnier, A; Tibi, A; Tubach, F; Van der Werf, S | 1 |
| Ali, NA; Haas, DM; Mangino, JE; Pan, X; Sopirala, MM; Turner, AN | 1 |
| Choi, JS; Kim, KH; Lee, HJ; Shin, DH | 1 |
| Andrianova, EN; Aver'ianov, AV; Babkin, AP; Bart, BIa; Epshteĭn, OI; Kostinov, MP; Kozyrev, OA; Minina, ES; Nechaev, VB; Petrov, DV; Putilovskiĭ, MA; Sel'kova, EP; Volchetskiĭ, AL | 1 |
| Chen, XY; Cui, DJ; Gao, H; Hu, SL; Huo, ZL; Lin, JT; Wang, AX; Wang, YZ; Wu, XD; Yu, XZ; Zhu, JH; Zhu, SH | 1 |
| Fukunaga, Y; Hajikano, M; Kawabata, K; Madenokouji, N; Matsuoka, K; Ninomiya, K | 1 |
| Monto, AS; Ohmit, SE | 1 |
| Hobo, S; Kondo, T; Matsumura, T; Tsujimura, K; Yamanaka, T | 1 |
| Kubo, T; Nishimura, H | 1 |
| Hirotsu, N; Horii, S; Ikematsu, H; Iwaki, N; Kanazawa, H; Kashiwagi, S; Kawai, N; Kawamura, K; Kawashima, T; Maeda, T; Nagai, T; Tanaka, O; Yamauchi, S | 1 |
| Gejyo, F; Li, D; Oguma, T; Saito, R; Sakai, T; Sasaki, A; Sato, I; Sato, M; Shobugawa, Y; Suzuki, H; Suzuki, Y; Tanabe, N; Tsukada, H | 1 |
| Ichihara, K; Suzuki, E | 1 |
| Carr, JA; Hayden, FG; Ives, JA; Kelly, L; Lambkin, R; Mendel, DB; Oxford, JS; Roberts, NA; Tai, CY | 1 |
3 review(s) available for oseltamivir and Fever
| Article | Year |
|---|---|
[Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Topics: Cough; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Fatigue; Fever; Humans; Influenza, Human; Meta-Analysis as Topic; Nonprescription Drugs; Nucleic Acids; Oseltamivir; Ribavirin | 2022 |
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid | 2021 |
EMERGING PATHOGENS: INFLUENZA - H7N9.
Topics: Animals; Antiviral Agents; Birds; Communicable Diseases, Emerging; Cough; Fever; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza Vaccines; Influenza, Human; Oseltamivir; Poultry; Radiography, Thoracic; Respiratory Distress Syndrome; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
16 trial(s) available for oseltamivir and Fever
| Article | Year |
|---|---|
Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases.
Topics: Capsules; Fever; Humans; Influenza, Human; Nausea; Oseltamivir; Phosphates; Tablets | 2023 |
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Europe; Female; Fever; Headache; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Time Factors; Treatment Outcome; Young Adult | 2020 |
[Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial].
Topics: Abdominal Pain; Antiviral Agents; Child; Diarrhea; Drug Administration Schedule; Female; Fever; Hospitals, Pediatric; Humans; Influenza, Human; Male; Oseltamivir; Treatment Outcome; Vomiting | 2017 |
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC
Topics: Activities of Daily Living; Antiviral Agents; Cost-Benefit Analysis; Female; Fever; Headache; Hospitalization; Humans; Influenza, Human; Male; Multicenter Studies as Topic; Myalgia; Nonprescription Drugs; Oseltamivir; Pneumonia; Pragmatic Clinical Trials as Topic; Prescription Drugs; Self Care; Symptom Assessment; Time Factors | 2018 |
Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial.
Topics: Adolescent; Adult; Aged; Antibodies; Antiviral Agents; CD4 Antigens; Female; Fever; Histamine; Humans; Influenza, Human; Interferon-gamma; Male; Middle Aged; Oseltamivir; Outpatients; Quality of Life; Time Factors; Treatment Outcome; Young Adult | 2016 |
Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Nausea; Oseltamivir; Prospective Studies; Virus Shedding; Vomiting; Young Adult | 2011 |
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
Topics: Adult; Antiviral Agents; Cytokines; Drugs, Chinese Herbal; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Statistics, Nonparametric; Treatment Outcome; Zanamivir | 2012 |
Viral load and clinical features in children infected with seasonal influenza B in 2006/2007.
Topics: Abdominal Pain; Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; Chills; Female; Fever; Humans; Infant; Influenza B virus; Influenza, Human; Male; Musculoskeletal Pain; Oseltamivir; Prospective Studies; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Viral Load | 2012 |
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cough; Drug Therapy, Combination; Enzyme Inhibitors; Family Characteristics; Female; Fever; Follow-Up Studies; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Middle Aged; Multivariate Analysis; Neuraminidase; Oseltamivir; Time Factors; Young Adult; Zanamivir | 2012 |
[Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
Topics: Adolescent; Adult; Antipyretics; Antiviral Agents; Body Temperature; CD4 Antigens; Female; Fever; Histamine; Humans; Influenza, Human; Interferon-gamma; Male; Middle Aged; Oseltamivir; Russia; Time Factors; Treatment Outcome; Young Adult | 2012 |
[A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].
Topics: Acetamides; Adult; Antiviral Agents; Double-Blind Method; Drug Administration Schedule; Female; Fever; Heart Diseases; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Treatment Outcome | 2004 |
Efficacy of oseltamivir phosphate to horses inoculated with equine influenza A virus.
Topics: Acetamides; Animals; Bronchoalveolar Lavage Fluid; Female; Fever; Horse Diseases; Horses; Influenza A Virus, H3N8 Subtype; Lung; Male; Orthomyxoviridae Infections; Oseltamivir; Time Factors | 2006 |
Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.
Topics: Administration, Oral; Adolescent; Analgesics, Non-Narcotic; Antiviral Agents; Child; Child, Preschool; DNA Primers; DNA, Viral; Drugs, Chinese Herbal; Female; Fever; Humans; Infant; Influenza A virus; Influenza, Human; Japan; Male; Medicine, Chinese Traditional; Oseltamivir; Phytotherapy; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2007 |
A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Female; Fever; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Treatment Outcome; Zanamivir | 2008 |
Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan.
Topics: Alphainfluenzavirus; Body Temperature; Child; Cities; Demography; Female; Fever; Humans; Influenza B virus; Influenza, Human; Japan; Male; Multivariate Analysis; Oseltamivir; Seasons; Time Factors; Treatment Outcome | 2008 |
The course of fever following influenza virus infection in children treated with oseltamivir.
Topics: Age Factors; Antiviral Agents; Body Temperature; Child; Child, Preschool; Female; Fever; Humans; Infant; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Regression Analysis; Time Factors; Treatment Outcome | 2008 |
45 other study(ies) available for oseltamivir and Fever
| Article | Year |
|---|---|
Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019-2020 season in Japan and detection of influenza virus with the PA E23K substitution.
Topics: Adolescent; Antiviral Agents; Child; Dibenzothiepins; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Morpholines; Nucleotidyltransferases; Oseltamivir; Pyridones; Seasons; Triazines | 2022 |
Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir.
Topics: Child; Child, Preschool; Dibenzothiepins; Fever; Humans; Influenza, Human; Oseltamivir; Retrospective Studies | 2023 |
Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
Topics: Adolescent; Child; Child, Preschool; Drug Approval; Enzyme Inhibitors; Fever; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Multivariate Analysis; Mutation; Neuraminidase; Oseltamivir; Proportional Hazards Models; Seasons; Temperature; Treatment Outcome; Young Adult | 2019 |
Weakness, Anemia, and Neutropenia in a 9-Year-Old Girl With Influenza.
Topics: Anemia; Antiviral Agents; Child; Diagnosis, Differential; Fatigue; Female; Fever; Gait Disorders, Neurologic; Humans; Influenza, Human; Muscle Weakness; Neutropenia; Oseltamivir; Spinal Cord Diseases; Vitamin B 12 Deficiency; Vomiting | 2020 |
Case report: A kidney transplant patient with mild COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Fever; Glucocorticoids; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisone; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult | 2020 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diarrhea; Dyspnea; Female; Fever; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Symptom Assessment; Young Adult | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018-2019 season and detection of variant influenza a viruses with polymerase acidic subunit substitutions.
Topics: Adolescent; Amino Acid Substitution; Antiviral Agents; Child; Child, Preschool; Dibenzothiepins; Female; Fever; Genetic Variation; Humans; Influenza A virus; Influenza, Human; Male; Morpholines; Oseltamivir; Prospective Studies; Pyridones; RNA-Dependent RNA Polymerase; Seasons; Triazines; Viral Proteins | 2020 |
Persistent hiccup: A rare presentation of COVID-19.
Topics: Baclofen; Biomarkers; COVID-19; COVID-19 Testing; Fever; Hiccup; Humans; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pharyngitis; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations; Dyspnea; Fatigue Syndrome, Chronic; Female; Fever; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Oseltamivir; Research Design; Ritonavir; SARS-CoV-2; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Survivors | 2021 |
Subtype-specific Clinical Presentation, Medical Treatment and Family Impact of Influenza in Children 1-5 Years of Age Treated in Outpatient Practices in Germany During Three Postpandemic Years, 2013-2015.
Topics: Antiviral Agents; Bronchitis; Child, Preschool; Epidemiological Monitoring; Female; Fever; Germany; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Male; Multiplex Polymerase Chain Reaction; Oseltamivir; Outpatients; Pandemics; Pharyngitis; Prospective Studies; Respiratory Tract Infections; Seasons | 2018 |
A case of H3N2 complicated by acute kidney injury secondary to rhabdomyolysis.
Topics: Acute Kidney Injury; Aged, 80 and over; Antiviral Agents; Bronchodilator Agents; Cough; Fever; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Methylprednisolone; Myalgia; Oseltamivir; Respiratory Distress Syndrome; Rhabdomyolysis; Treatment Outcome | 2018 |
Detection of influenza A(H1N1)pdm09 virus in a patient travelling from Shanghai to Italy in July 2018: an uncommon clinical presentation in a non-seasonal period.
Topics: Adult; Antiviral Agents; China; Communicable Diseases, Imported; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Italy; Leukopenia; Male; Oseltamivir; Phylogeny; Seasons | 2019 |
Oseltamivir treatment for influenza in hospitalized children without underlying diseases.
Topics: Analysis of Variance; Antiviral Agents; Chi-Square Distribution; Child, Preschool; Female; Fever; Hospitalization; Humans; Infant; Influenza, Human; Length of Stay; Male; Oseltamivir; Retrospective Studies | 2013 |
Diagnosis and treatment of children with severe influenza A from the 2009/2010 pandemic in Tianjin, China.
Topics: Administration, Intravenous; Adolescent; Antiviral Agents; Child; Child, Preschool; China; Female; Fever; Glucocorticoids; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Methylprednisolone; Oseltamivir; Pandemics; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Severity of Illness Index; Treatment Outcome | 2014 |
Contribution of systematic RT-PCR screening for influenza during the epidemic season.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Cross Infection; Delayed Diagnosis; Diagnosis, Differential; Disease Outbreaks; Emergency Service, Hospital; Female; Fever; France; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lung Diseases; Male; Middle Aged; Oseltamivir; Patients' Rooms; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Seasons; Sensitivity and Specificity | 2014 |
Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Topics: Acids, Carbocyclic; Antiviral Agents; Child; Child, Preschool; Cyclopentanes; Enzyme Inhibitors; Female; Fever; Guanidines; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pyrans; Severity of Illness Index; Sialic Acids; Time Factors; Treatment Outcome; Viral Proteins; Virus Shedding; Zanamivir | 2015 |
Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013.
Topics: Antiviral Agents; Behavioral Symptoms; Child; Fever; Humans; Influenza, Human; Japan; Oseltamivir; Retrospective Studies | 2014 |
Effect of influenza-induced fever on human bioimpedance values.
Topics: Adolescent; Adult; Antiviral Agents; Body Composition; Child; Child, Preschool; Disease Outbreaks; Electric Impedance; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Venezuela; Young Adult | 2015 |
Oseltamivir produces hypothermic and neuromuscular effects by inhibition of nicotinic acetylcholine receptor functions: comparison to procaine and bupropion.
Topics: Animals; Bradycardia; Bupropion; Drug Synergism; Fever; Hypotension; Male; Mice; Muscle Relaxation; Neuromuscular Agents; Nicotinic Antagonists; Oseltamivir; Procaine; Rats; Receptors, Nicotinic | 2015 |
Experience of influenza A H1N1 in a paediatric emergency unit.
Topics: Antiviral Agents; Child; Child, Preschool; Diarrhea; Emergency Service, Hospital; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphopenia; Male; Myalgia; Oseltamivir; Retrospective Studies; Risk Factors; Treatment Outcome; Turkey | 2015 |
Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009-2010.
Topics: Adolescent; Adult; Antiviral Agents; Asthma; Central America; Comorbidity; Costa Rica; Disease Outbreaks; Dominican Republic; El Salvador; Female; Fever; Guatemala; Honduras; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Nicaragua; Oseltamivir; Pregnancy; Pulmonary Disease, Chronic Obstructive; Young Adult | 2015 |
Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Fever; Humans; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Oseltamivir; Retrospective Studies; Treatment Outcome; Zanamivir | 2008 |
A/H1N1 flu pandemic. Managing neutropenic sepsis.
Topics: Antineoplastic Agents; Antiviral Agents; Diagnosis, Differential; Fever; Humans; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Neutropenia; Oseltamivir | 2009 |
Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Mutation; Neuraminidase; Oseltamivir; Time Factors; Zanamivir | 2009 |
Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
Topics: Adult; Antiviral Agents; Cohort Studies; Disease Outbreaks; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Singapore; Statistics, Nonparametric; Virus Shedding; Young Adult | 2010 |
Fever, cough, and hypoxia in a pregnant woman.
Topics: Adult; Antiviral Agents; Cough; Female; Fever; Humans; Hypoxia; Influenza A Virus, H1N1 Subtype; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Vomiting | 2010 |
Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
Topics: Adolescent; Amino Acid Substitution; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Female; Fever; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Microbial Sensitivity Tests; Mutation, Missense; Nasopharynx; Neuraminidase; Oseltamivir; Treatment Outcome; Viral Proteins; Zanamivir | 2010 |
Pandemic (H1N1) 2009, Shanghai, China.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; China; Disease Outbreaks; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; RNA, Viral; Time Factors; Travel | 2010 |
An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
Topics: Antiviral Agents; Fever; Gentamicins; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Zanamivir | 2010 |
Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.
Topics: Adolescent; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Italy; Lung Diseases; Male; Medical Records; Nervous System Diseases; Oseltamivir; Treatment Outcome | 2010 |
Retrospective analysis of pediatric cancer patients diagnosed with the pandemic H1N1 influenza infection.
Topics: Adolescent; Child; Child, Preschool; Fever; Hematologic Neoplasms; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neoplasms; Oseltamivir; Pandemics; Retrospective Studies; Time Factors; Young Adult | 2011 |
Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
Topics: Adolescent; Adult; Antiviral Agents; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pandemics; Seasons; Young Adult; Zanamivir | 2011 |
[Clinical course of influenza A(H1N1)v in children treated in Warsaw in season 2009/2010].
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Communicable Diseases, Emerging; Comorbidity; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia; Poland; Retrospective Studies; Seasons; Treatment Outcome; Urban Population | 2010 |
Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit.
Topics: Adult; Antiviral Agents; Child; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Neoplasms; Oncology Service, Hospital; Oseltamivir; Prospective Studies; Treatment Outcome | 2011 |
Clinical significance of pleural effusion in the new influenza A (H1N1) viral pneumonia in children and adolescent.
Topics: Adolescent; Antistreptolysin; Antiviral Agents; C-Reactive Protein; Child; Child, Preschool; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Length of Stay; Lymphopenia; Male; Oseltamivir; Oxygen Inhalation Therapy; Pleural Effusion; Pneumonia, Viral; Retrospective Studies; Severity of Illness Index | 2012 |
Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
Topics: Adolescent; Adult; Antiviral Agents; Child; Drug Resistance, Viral; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Inhibitory Concentration 50; Japan; Male; Mutation; Oseltamivir; Pandemics; Seasons; Sequence Analysis, DNA; Treatment Outcome; Virus Shedding; Young Adult | 2012 |
Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Kaplan-Meier Estimate; Male; Oseltamivir; Prospective Studies; Viral Load | 2012 |
Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Enzyme Inhibitors; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Inhibitory Concentration 50; Male; Middle Aged; Neuraminidase; Oseltamivir; Seasons; Severity of Illness Index; Treatment Outcome; Young Adult; Zanamivir | 2013 |
Effect of fever on hospital presentation, diagnosis, and treatment in patients with H1N1/09 influenza.
Topics: Adult; Antiviral Agents; Comorbidity; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Ohio; Oseltamivir; Outcome Assessment, Health Care; Patient Admission; Retrospective Studies; Tertiary Care Centers; Time Factors; United States | 2013 |
Leukocytoclastic vasculitis associated with influenza A virus infection.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Child, Preschool; Female; Fever; Humans; Influenza A virus; Influenza, Human; Nasopharynx; Oseltamivir; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; Skin; Vasculitis, Leukocytoclastic, Cutaneous | 2012 |
Frequency and effects of bacterial infection in children with influenza under oseltamivir treatment.
Topics: Acetamides; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Female; Fever; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Pneumococcal Infections; Superinfection; Time Factors | 2006 |
Symptomatic predictors of influenza virus positivity in children during the influenza season.
Topics: Acetamides; Aging; Antiviral Agents; Child; Child, Preschool; Cough; Fever; Guanidines; Headache; Humans; Infant; Influenza, Human; Logistic Models; Muscular Diseases; Odds Ratio; Oseltamivir; Pyrans; Risk Factors; Seasons; Sialic Acids; Zanamivir | 2006 |
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
Topics: Acetamides; Amino Acid Substitution; Animals; Antiviral Agents; Body Weight; Cell Line; Disease Models, Animal; Drug Resistance, Viral; Ferrets; Fever; Humans; In Vitro Techniques; Inflammation; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mice; Mice, Inbred BALB C; Mutagenesis, Site-Directed; Mutation; Neuraminidase; Oseltamivir; Sequence Analysis, DNA; Virus Replication | 2002 |